NeuroOne Medical Technologies Corporation Other Noncash Income (Expense)
NeuroOne Medical Technologies Corporation (NMTC) reported Other Noncash Income (Expense) of -$109.83 thousand for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-12-15
- NeuroOne Medical Technologies Corporation other noncash income (expense) for the quarter ending 2023-09-30 was -$28.27K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for the quarter ending 2023-06-30 was -$27.68K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for the quarter ending 2023-03-31 was -$27.11K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for the quarter ending 2022-12-31 was -$26.77K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for fiscal 2023 was -$109.83K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for fiscal 2022 was -$107.59K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for fiscal 2021 was -$66.38K.
- NeuroOne Medical Technologies Corporation other noncash income (expense) for fiscal 2020 was -$22.94K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$28.27K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$55.95K derived: sum of 2 quarters · filed 2023-12-15 | -$83.06K derived: sum of 3 quarters · filed 2023-12-15 | -$109.83K 10-K · filed 2023-12-15 |
| 2023-06-30 | -$27.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$54.80K derived: sum of 2 quarters · filed 2023-08-14 | -$81.57K 10-Q · filed 2023-08-14 | -$109.14K derived: sum of 4 quarters · filed 2023-12-15 |
| 2023-03-31 | -$27.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$53.89K 10-Q · filed 2023-05-12 | -$81.46K derived: sum of 3 quarters · filed 2023-12-15 | -$108.57K derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-12-31 | -$26.77K 10-Q · filed 2023-02-13 | -$54.34K derived: sum of 2 quarters · filed 2023-12-15 | -$81.46K derived: sum of 3 quarters · filed 2023-12-15 | -$108.13K derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-09-30 | -$27.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$54.69K derived: sum of 2 quarters · filed 2023-12-15 | -$81.36K derived: sum of 3 quarters · filed 2023-12-15 | -$107.59K 10-K · filed 2023-12-15 |
| 2022-06-30 | -$27.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$53.78K derived: sum of 2 quarters · filed 2023-08-14 | -$80.02K 10-Q · filed 2023-08-14 | -$105.35K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$26.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$52.91K 10-Q · filed 2023-05-12 | -$78.23K derived: sum of 3 quarters · filed 2023-05-12 | -$92.48K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$26.23K 10-Q · filed 2023-02-13 | -$51.56K derived: sum of 2 quarters · filed 2023-02-13 | -$65.81K derived: sum of 3 quarters · filed 2023-02-13 | -$78.77K derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | -$25.33K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | -$39.58K derived: sum of 2 quarters · filed 2022-12-22 | -$52.53K derived: sum of 3 quarters · filed 2022-12-22 | -$66.38K 10-K · filed 2022-12-22 |
| 2021-06-30 | -$14.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$27.21K derived: sum of 2 quarters · filed 2022-08-11 | -$41.06K 10-Q · filed 2022-08-11 | -$54.66K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$12.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$26.80K 10-Q · filed 2022-05-12 | -$40.41K derived: sum of 3 quarters · filed 2022-05-31 | -$45.71K derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-12-31 | -$13.85K 10-Q · filed 2022-02-14 | -$27.46K derived: sum of 2 quarters · filed 2022-05-31 | -$32.75K derived: sum of 3 quarters · filed 2022-05-31 | -$26.92K derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | -$13.61K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | -$18.91K derived: sum of 2 quarters · filed 2022-05-31 | -$13.07K derived: sum of 3 quarters · filed 2022-05-31 | -$22.94K 10-K/A · filed 2022-05-31 |
| 2020-06-30 | -$5.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $535.00 derived: sum of 2 quarters · filed 2021-08-13 | -$9.34K 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $5.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | -$4.04K 10-Q · filed 2021-05-14 | ||
| 2019-12-31 | -$9.87K 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |